Magnetic resonance in the era of molecular imaging of cancer

Magnetic resonance imaging (MRI) has played an important role in the diagnosis and management of cancer since it was first developed, but other modalities also continue to advance and provide complementary information on the status of tumors. In the future, there will be a major continuing role for noninvasive imaging in order to obtain information on the location and extent of cancer, as well as assessments of tissue characteristics that can monitor and predict treatment response and guide patient management. Developments are currently being undertaken that aim to provide improved imaging methods for the detection and evaluation of tumors, for identifying important characteristics of tumors such as the expression levels of cell surface receptors that may dictate what types of therapy will be effective and for evaluating their response to treatments. Molecular imaging techniques based mainly on radionuclide imaging can depict numerous, specific, cellular and molecular markers of disease and have unique potential to address important clinical and research challenges. In this review, we consider what continuing and evolving roles will be played by MRI in this era of molecular imaging. We discuss some of the challenges for MRI of detecting imaging agents that report on molecular events, but highlight also the ability of MRI to assess other features such as cell density, blood flow and metabolism which are not specific hallmarks of cancer but which reflect molecular changes. We discuss the future role of MRI in cancer and describe the use of selected quantitative imaging techniques for characterizing tumors that can be translated to clinical applications, particularly in the context of evaluating novel treatments.     

微波消解-ICP-MS测定胃癌和癌旁组织中的微量元素

采用微波消解技术,建立了人体胃组织中22种微量元素含量的ICP-MS测定方法.样品经恒温干燥后,采用硝酸-过氧化氢体系微波消解,优化ICP-MS得到最佳工作参数,测定时以Ge,Rh作为内标来校正由于基体效应和信号漂移对测量造成的影响.该方法的回收率为94.7％-105.6％,相对标准偏差为2.9％-13.4％,检出限为...     

Nanobioelectroanalysis Based on Carbon/Inorganic Hybrid Nanoarchitectures

The emergence of nanotechnology has opened new horizons for electrochemical biosensors. This review highlights new concepts for electrochemical biosensors based on different carbon/inorganic hybrid nanoarchitectures. Particular attention will be given to hybrid nanostructures involving 1‐ or 2‐dimensional carbon nanotubes or graphene along with inorganic nanoparticles (gold, platinum, quantum dot (QD), metal oxide). Latest advances (from 2007 onwards) in electrochemical biosensors based on such hybrids of carbon/inorganic‐nanomaterial heterostructures are discussed and illustrated in connection to enzyme electrodes for blood glucose or immunoassays of cancer markers. Several strategies for using carbon/inorganic nanohybrids in such bioaffinity and biocatalytic sensing are described, including the use of hybrid nanostructures for tagging or modifying electrode transducers, use of inorganic nanomaterials as surface modifiers along with carbon nanomaterial label carriers, and carbon nanostructure‐based electrode transducers along with inorganic amplification tags. The implications of these nanoscale bioconjugated hybrid materials on the development of modern electrochemical biosensors are discussed along with future prospects and challenges.     

Rapid determination of multidrug resistance-associated protein in cancer cells by capillary electrophoresis immunoassay

The adenosine triphosphate (ATP) binding-cassette (ABC) transporters are a superfamily of cellular proteins that have been partly implicated as a cause of multidrug resistance (MDR) in cancer cells. The ABC superfamily consists of P-glycoprotein, multidrug resistance-associated proteins (MRP) and breast cancer-related proteins, of which MRP is of particular interest because of its ability to efflux a broader range of substrates. Since MRP1 is the most prominent member of the MRP family, a simple technique is needed for its quantification. We developed a simple, fast (total analysis time of 3h) capillary electrophoresis immunoassay (CEIA) for the quantification of MRP1 in cancer cells. MRP1 antibody was labeled with fluorescein isothiocyanate. The labeled antibody was incubated with the cell lysate for a fixed interval (1h), after which the cell lysate mixture was directly injected into the capillary to separate the complex of MRP1 and its antibody from free antibody. The noncompetitive CEIA method had a limit of detection of 0.2 nM and a good linear range (1.7-14.9×10(4) cells), and was fairly reproducible (RSD<10%). The results showed that two cell lines, A549 and RDES, expressed MRP1 in the absence of doxorubicin (DOX), with A549 registering a higher expression. Compared to DOX-free cancer cells, there was an acceleration of MRP1 expression during the 12h-exposure to DOX, after which the level of expression remained nearly constant as the intracellular accumulation of DOX decreased. The results obtained in this work indicate that the developed CEIA method is useful for relative quantification of MRPs in cancer cells.     

Ferrocene-indole hybrids for cancer and malaria therapy

We report the synthesis, characterization, and cytotoxic and antimalarial activity of ferrocene-indole hybrids 8-14. The 2-phenylindole scaffold was chosen because of its potent antimitotic activity and ferrocene was chosen following the development of ferrocifens, ferrocene derivatives of tamoxifen, which are prototypes of a new family of organometallic anti-estrogens. Ferrocene-indole hybrids 8-14 and their corresponding organic analogues 1-7 showed only moderate antimalarial activities, while ferrocene-indole hybrids 11 and 12 showed excellent in vitro activities against the A549 human carcinoma cell line, with IC₅₀ values of 5 and 7 μM respectively. These ferrocene-indole hybrids were up to 25-fold more potent as cytotoxic agents than their purely organic analogues.     

Synthesis of gemini triethylene-tetramine bridged bis-tridentate iron(III) chelators

Eight gemini bis-2-(2-hydroxyphenyl)-thiazole-4-carboxamide and -thiocarboxamide (BHPTC) chelators were efficiently synthesized. Mass spectrometry showed these compounds all form 1:1 complexes with iron(III). Three of these chelators exhibit promising antiproliferative activities when tested on human cancerous cell lines.     

Design, synthesis, and biological evaluation of estrone-derived hedgehog signaling inhibitors

The design, synthesis, and biological evaluation of new analogs of the naturally occurring compound cyclopamine, a hedgehog signaling inhibitor, are described. Structure-activity relationship studies lead to an evolving model for the pharmacophore of this medically promising compound class of anti-cancer chemotherapeutic agents.     

Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension

Deacety mycoepoxydiene (DM), extracted from Phomopsis sp. A123 of thalassiomycetes, is a novel and potent anti-cancer agent. Due to its physicochemical characteristics, the drug, a poorly water-soluble weak acid, shows poor solubility and dissolution characteristics. To improve the solubility and dissolution, formulation of DM as nanosuspension has been performed in this study. Nanosuspensions were developed by high-pressure homogenization (HPH) (DissoCubes(?) Technology) and transformed into dry powder by freeze-drying. The nanosuspension produced was then investigated using optical microscope, photon correlation spectroscopy (PCS), zeta potential measurement, SEM, TEM, AFM, DSC and XRD. To verify the theoretical hypothesis on the benefit of increased surface area, in vitro saturation solubility and dissolution profile were investigated. In addition, the in vitro cell cytotoxicity was examined. Results showed that a narrow size distributed nanosuspension composed of unchanged crystalline state with a mean particle size of 515±18 nm, a polydispersity index of 0.12±0.03 and a zeta potential of -23.1±3.5 mV was obtained. In the in vitro dissolution test an accelerated dissolution velocity and increased saturation solubility could be shown for the MD nanosuspension. The in vitro cytotoxicity experiments provided evidence for an enhanced efficacy of the DM nanosuspension formulation compared to free DM solution. Taken together, these results illustrate the opportunity to formulate DM in nanosuspension form as an anti-prostate cancer delivery system.     

Methoxylation and Glycosylation Effect on the Redox Mechanism of Citroflavones

The methoxylation and glycosylation effect on the redox mechanism of citroflavones, isorhoifolin, linarin, diosmetin and diosmin, was investigated. All citroflavones’ hydroxyl groups can be electrochemically oxidised, and the oxidation at the B‐ring occurs at a lower potential than at the A‐ring. The electrochemical oxidation is irreversible, pH‐dependent, with occurrence of one or two oxidation products, which undergo reversible redox reactions, depending on the number of OH substituents on the molecule. The glycosylation leads to a steric effect and decreasing of the oxidation peak currents whereas the methylation involves the formation of nonelectroactive oxidation products.     

Fabrication of a Colorimetric Carcino-Embryonic Antigen Sensor Using High-Activity DNAzyme as a Catalytic Label

Detection of biomarkers in a biologically complex mixture remains a major challenge. Herein, an ultrasensitive colorimetric sandwich sensor for carcino-embryonic antigen (CEA) detection is introduced. The DNAzyme was tethered to biotinylated monoclonal antibodies (McAbs) which serve as the sensing element to recognize the target protein and was then introduced on to the CEA-McAbs assembled micro plate. The CEA was captured in a sandwich assay by the McAbs. The peroxidase-like DNAzyme catalyzed the oxidation of 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid), which generated a blue-green colorimetric signal. This method detected CEA in a serum-containing medium at a concentration as low as 10 nM. This strategy is a promising tool for bioanalytical and clinical applications.